Heart failure associated with sunitinib
β
Aarif Y. Khakoo; Christos M. Kassiotis; Nizar Tannir; Juan Carlos Plana; Marc Ha
π
Article
π
2008
π
John Wiley and Sons
π
English
β 193 KB
## Abstract ## BACKGROUND. Sunitinib malate is a novel multitargeted receptor tyrosine kinase inhibitor with established efficacy in the treatment of metastatic renal cell carcinoma and imatinibβresistant gastrointestinal stromal tumor. This report describes the development of heart failure in can